Walter Stadler, MD

@wmstadler.bsky.social

Chief Clinical Officer, City of Hope Chicago

PSM is incredibly difficult to define & there are other benefits to not developing advanced prostate cancer (e.g. avoiding androgen ablation). As such mortality statistics for screening any disease with decades long natural history are a, but not the only metric we should follow.

Andrew Vickers@vickersbiostats.bsky.social · 7mo ago

PSA screening reduces cancer-specific mortality (PCSM). Questions remain about effect on all-cause (OS). PSA could reduce PCSM not OS only with deaths from other causes, eg complications of surgery. Please reply with list of screening-induced causes of death.

PBS News is not going anywhere. We will continue our work without fear or favor, as we have for nearly five decades on the air. We are profoundly grateful to Viewers Like You for your loyalty and unwavering support.

April is Testicular Cancer Awareness Month – a time to recognise the prevalence of this Below the Belt cancer and the incredible people working to improve outcomes. Their dedication is driving better treatments, improving patient care, and bringing hope to those affected.💙👏

Bild

Katie provides the moral imperative far more eloquently than I can. For those who require an economic argument, the US research enterprise is the most robust in the world creating $100B in wealth. It is one of our most successful exports.

Katie Coleman@katiekickscancer.bsky.social · 2y ago

has crushed me in a way I can not describe. If you have ever celebrated me and my fight against the odds, I need you to also support science in this moment. This isn't about politics, it crosses party lines. Cancer research needs us right now.

The response of the science community to the last month is not about one statement or action. It's about all of us with our different frames. For Science's part, we are doing what we have always done and have no plans to change. My thoughts on what we can do. www.science.org/doi/10.1126/...

Come together, right now

The chaos, conflicting information, firings, and hurtful rhetoric of the Trump administration’s approach to science over the past month are causing anxiety, grief, and concern for the scientific commu...

science.org

We applaud new draft guidance from the @fda.gov & OHRP on incl tissue biopsies in clinical trials. In The Cancer Letter editorial, we stated guidance closely aligns w our ongoing efforts to improve ethics of research biopsies, esp biopsies that are mandatory. More: brnw.ch/21wQetz

ASCO Applauds New Draft Guidance on Including Tissue Biopsies in Clinical Trials

ASCO welcomes new draft guidance on including tissue biopsies in clinical trials.

brnw.ch